PHARMAROTH LABS, INC. |
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.000001 USD | -.--% |
|
-.--% | -.--% |
| 2015 | PharmaRoth Labs, Inc. Receives Additional Order from Marcas de Renombre | CI |
| 2014 | PharmaRoth Labs, Inc. Announces New Distribution Agreement with Biotechnology Co., Ltd | CI |
Business Summary
Number of employees: 2
Sales per Business
| USD in Million | 2016 | Weight | 2017 | Weight | Delta |
|---|---|---|---|---|---|
Nutraceutical Drugs
100.0
%
| 0 | 100.0 % | 0 | 100.0 % | -31.08% |
Sales per region
| USD in Million | 2016 | Weight | 2017 | Weight | Delta |
|---|---|---|---|---|---|
Americas
100.0
%
| 0 | 100.0 % | 0 | 100.0 % | -31.08% |
Managers
| Managers | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | - | 30/08/10 | |
Barry W. Hall
DFI | Director of Finance/CFO | 76 | 21/01/13 |
Members of the board
| Members of the board | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | - | 30/08/10 |
Share class
| Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
|---|---|---|---|---|---|
| Stock A | 1 | 394,014,970 | 121,850,000 ( 30.93 %) | 0 | 30.93 % |
Company contact information
PharmaRoth Labs, Inc.
10080 West Alta Drive Suite 115
89145, Las Vegas
+212-541-6222
http://www.pharmaroth.com
Sector
| 1st Jan change | Capi. | |
|---|---|---|
| -.--% | 390 | |
| +30.95% | 695B | |
| +26.51% | 568B | |
| -4.63% | 361B | |
| +19.67% | 330B | |
| +3.86% | 283B | |
| +16.70% | 239B | |
| +8.78% | 204B | |
| -7.93% | 198B | |
| +8.70% | 168B |
- Stock Market
- Equities
- ROTH Stock
- Company PharmaRoth Labs, Inc.
